Filing Details
- Accession Number:
- 0001019687-13-000365
- Form Type:
- 4/A
- Zero Holdings:
- No
- Publication Time:
- 2013-02-05 15:58:45
- Reporting Period:
- 2012-12-14
- Filing Date:
- 2013-02-05
- Accepted Time:
- 2013-02-05 15:58:45
- Original Submission Date:
- 2012-12-18
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1140098 | Advanced Cell Technology Inc. | ACTC | Pharmaceutical Preparations (2834) | 870656515 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1317093 | Robert Lanza | C/O Advanced Cell Technology 33 Locke Drive Marlborough MA 01752 | Chief Scientific Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2012-12-14 | 20,000 | $0.06 | 23,937,575 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2012-12-14 | 440,000 | $0.06 | 23,497,575 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2012-12-14 | 40,000 | $0.06 | 23,457,575 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2012-12-14 | 545,490 | $0.06 | 22,912,085 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2012-12-14 | 150,000 | $0.06 | 22,762,085 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2012-12-14 | 100,000 | $0.06 | 22,662,085 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2012-12-14 | 43,000 | $0.06 | 22,619,085 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- On December 18, 2012, the reporting person filed a Form 4 that mistakenly reported an issuance of 1,285,714 shares of the issuer's common stock to the reporting person. This issuance did not in fact occur. Instead, 1,285,714 shares of restricted stock that were originally issued to the reporting person on August 8, 2011 vested, which shares of common stock were reported on a Form 4 filed on August 18, 2011. As of December 14, 2012, the reporting person beneficially owned only 22,619,085 shares of common stock.
Billionaire Hedge Funds
